Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, reduce glucagon https://ihannaiilh114570.blog5.net/88151659/novel-agents-in-diabetes-management